U.S. Tech Hardware Stock News

General Motors is facing a class action lawsuit tied to reported defects in its Cadillac Lyriq EV. The company has paused sales of new Corvette models due to a safety system compliance issue. GM has removed its historic branding from Detroit's Renaissance Center, its long time riverfront headquarters. For investors watching General Motors, NYSE:GM, these developments touch product quality, regulatory compliance, and corporate identity at the same time. The stock closed at $76.74, with a 1...

Markets are being pulled in different directions by energy prices, interest rate expectations, and shifting inflation trends, and that can make it harder to know where to focus. One clear anchor is leadership that is deeply invested in its own business. Founder led companies, where leaders typically hold meaningful stakes and think in decades rather than quarters, can offer a different quality of commitment. This article looks at our Top Founder Led Companies screener and highlights three...

In recent commentary, Herc Holdings (NYSE:HRI) was reported to have seen costs rise faster than revenue over the past five years, contributing to a 7.3 percentage point decline in operating margin and a net-debt-to-EBITDA ratio of 5 times that may limit its access to new capital. This combination of margin compression and elevated leverage raises questions about Herc’s financial flexibility and capacity to fund growth without resorting to potentially dilutive equity issuance. Next, we will...

Nurix Therapeutics (NRIX) opened 2026 with Q1 revenue of US$6.3 million and a basic EPS loss of US$0.79, while trailing twelve month figures show revenue of US$71.8 million against a basic EPS loss of US$3.17, framing a business that is still firmly in investment mode. Over the past year, the company has seen quarterly revenue range from US$6.3 million to US$44.1 million and basic EPS move between a loss of US$0.52 and a loss of US$1.03, giving investors a clear view of how top line progress...

Kiniksa Pharmaceuticals International (NasdaqGS:KNSA) has launched Heart’s Home, a Direct-to-Consumer campaign focused on ARCALYST for recurrent pericarditis. The campaign aims to expand awareness and empower patients about the only FDA approved therapy for recurrent pericarditis. Heart’s Home represents a new commercial effort to reach patients directly outside the traditional physician focused model. Kiniksa Pharmaceuticals International, listed on NasdaqGS:KNSA, develops and...

BOK Financial (NasdaqGS:BOKF) has promoted Scott Andrews to lead its Specialized Industries Banking group. The appointment follows the planned retirement of Executive Vice President Brad Vincent. The transition affects key lines of business including commercial real estate, energy, and healthcare banking. BOK Financial’s Specialized Industries Banking unit sits at the core of its commercial franchise, with exposure to sectors that tend to be closely watched by lenders and regulators. Areas...

Analyst sentiment shift puts Curtiss-Wright (CW) in focus Recent increases in analyst earnings estimates for Curtiss-Wright (CW), along with strong growth projections and favorable investment ratings, have drawn fresh attention to the stock as investors reassess the company’s earnings outlook. See our latest analysis for Curtiss-Wright. The recent shift in analyst sentiment has arrived alongside strong price momentum, with Curtiss-Wright’s share price up 4.6% over the past week, a 25.1% 90...

Aehr Test Systems (AEHR) has released its Q3 2026 numbers, reporting revenue of US$10.3 million and a basic EPS loss of US$0.10, alongside net income excluding extra items of a US$3.2 million loss. The company has seen quarterly revenue move between US$13.5 million and US$18.3 million since Q2 2025, while basic EPS has ranged from a profit of US$0.78 per share on a trailing twelve month basis in 2025 to a loss of US$0.38 per share over the most recent twelve month window. This keeps the focus...

Sandisk (NasdaqGS:SNDK) is investing $1b to acquire a stake in Nanya Technology. The deal includes a new multi year DRAM supply agreement between the two companies. This transaction follows Sandisk's recent move to operate as an independent public company. For investors watching Sandisk at a share price of $780.9, this capital deployment comes after very strong recent returns. The stock is up 12.7% over the past week, 32.6% over the past month and 183.7% year to date. The 1 year return is...

Wondering whether Marvell Technology at around US$114 a share still offers value, or if most of the opportunity is already reflected in the price. The stock has seen strong moves over multiple periods, with returns of 7.3% over 7 days, 23.5% over 30 days, 28.0% year to date, 88.4% over 1 year, 192.3% over 3 years and 142.6% over 5 years. These returns sit against a backdrop of ongoing attention on semiconductor names involved in high performance computing, networking and data infrastructure...

In its fiscal third quarter ended February 28, 2026, Applied Digital reported revenue of US$126.64 million, while net loss widened to US$100.86 million and loss per share from continuing operations increased to US$0.36. Over the first nine months of fiscal 2026, revenue nearly doubled to US$352.56 million as the company shifted toward AI-focused data centers, even as it continued to report sizeable losses and absorbed rising interest costs tied to its debt-funded expansion. With revenue...

Adecoagro (AGRO) has drawn fresh attention after its shares moved sharply in recent months, with the stock posting a notable gain over the past 3 months and a meaningful rise over the past month. See our latest analysis for Adecoagro. That move comes after a sharp run up, with an 80.40% 3 month share price return and an 83.89% year to date share price return, alongside a 37.43% 1 year total shareholder return that points to strong recent momentum despite the latest pullback. If Adecoagro’s...

If you are wondering whether PagSeguro Digital's current share price truly reflects its underlying worth, this article walks through the key signals you can use to judge that. The stock recently closed at US$10.76, with returns of 2.2% over the last 7 days, 7.8% over 30 days, 11.3% year to date, 35.4% over 1 year, 31.3% over 3 years and a 75.3% decline over 5 years. Recent coverage has focused on PagSeguro Digital's position within diversified financials and how changing views on digital...

If you are wondering whether Booking Holdings at US$181 is starting to look like value or is still pricing in a lot of optimism, this breakdown will help you put the current share price in context. The stock has returned 8.1% over the last 7 days and 1.9% over the last 30 days, but is still showing a -15.0% return year to date and a -1.2% return over the last year, compared with longer term returns of 81.0% over 3 years and 87.8% over 5 years. Recent coverage has focused on how Booking...

CVB Financial received final regulatory approval for its merger with Heritage Commerce. The companies now have clearance to close the transaction, which is expected to happen imminently. The approval moves the combination from planning to full integration for customers, employees, and shareholders. For investors tracking CVB Financial, ticker NasdaqGS:CVBF, the timing of this approval comes with the stock at $20.3 and a value score of 4. Over the past year the shares have returned 20.8%,...

Abbott Laboratories (ABT) is back in focus after announcing that its Precision Oncology test portfolio will be integrated into Flatiron Health’s OncoEMR platform, giving thousands of oncology providers streamlined digital access to its cancer diagnostics. See our latest analysis for Abbott Laboratories. The Precision Oncology integration comes at a time when Abbott’s share price has seen a 1.7% 1 day gain but a 30 day share price return decline of 8.07% and a year to date share price return...

Royalty Pharma (RPRX) is back in focus after announcing a US$500 million R&D co funding agreement with Johnson & Johnson to advance JNJ-4804, an investigational autoimmune therapy targeting IL-23 and TNF pathways. See our latest analysis for Royalty Pharma. The J&J co funding news lands on top of an already strong run, with Royalty Pharma’s 90 day share price return of 18.98% and 1 year total shareholder return of 51.96% suggesting momentum has been building. If this kind of deal making has...

Event driven snapshot of Gibraltar Industries With no single headline event setting the tone, Gibraltar Industries (ROCK) draws attention through its recent trading performance, mixed short term and multi month returns, and value focused metrics that many investors are reassessing. See our latest analysis for Gibraltar Industries. The recent 5.35% 1-day share price return and 2.50% 7-day share price return contrast with a 90-day share price return decline of 21.39% and a 1-year total...

If you are wondering whether CF Industries Holdings at around US$126 still offers value or if the opportunity has passed, this breakdown is designed to help you frame that question clearly. The stock has had a mixed short term pattern, with a 1.4% decline over the last week, a 13.6% gain over the last month, and returns of 57.4% year to date and 83.1% over the last year. Recent coverage has focused on CF Industries Holdings as part of broader conversations about materials and fertilizers,...

With Pagaya Technologies trading at around US$12.37, this article considers whether the current price suggests an opportunity or already reflects a high degree of optimism, and explores what the share price might be implying about the business. The stock has returned 5.7% over the last 7 days and 6.8% over the last 30 days. Year to date it shows a 44.5% decline and a 22.0% return over the last year, figures that can influence how the market views both its potential and its risks. Recent...

Event context and recent price action HeartFlow (HTFL) has attracted fresh attention after a recent uptick in its share price, building on a 0.8% gain over the past day and a 10.5% move across the past week. That short term strength sits alongside a 16.8% rise over the past month, set against a 19.1% decline across the past 3 months and a 6.5% negative return year to date. Together, these figures give investors a mixed recent picture. See our latest analysis for HeartFlow. Putting that into...

Futu Holdings (NasdaqGM:FUTU) has announced a substantial cash dividend for ordinary shareholders and ADS holders. The dividend represents a direct cash return, with payment scheduled following the relevant record and ex dividend dates set by the company. This payout applies to both holders of the company’s ordinary shares and its American Depositary Shares. Futu Holdings operates as a digital brokerage and wealth management platform, serving investors primarily through its online trading...

Nadia Karkar has left TPG Rise to become a Managing Partner at 500 Global. She previously led global business development and TPG Rise's Global South Initiative. Her departure affects TPG's climate focused investing and relationships in emerging markets. TPG, traded as NasdaqGS:TPG, is in the spotlight after this leadership change within its impact investing arm. The shares most recently closed at $38.26, with a 3 year return of 47.4% and a 1 year return of a 13.4% decline. The stock is...

Cinemark Holdings recently reported that it achieved an all-time high five-day Easter weekend domestic box office, powered by a diverse film slate and exceptionally strong attendance led by The Super Mario Galaxy Movie. The company also delivered its best-ever merchandise program tied to the film, suggesting that immersive activations and themed food and beverage can materially boost non-ticket revenue and deepen audience engagement. We’ll now examine how this record Easter performance,...